HOUSE_OVERSIGHT_024663.jpg
1.81 MB
Extraction Summary
0
People
4
Organizations
0
Locations
0
Events
0
Relationships
3
Quotes
Document Information
Type:
Investment report / industry analysis
File Size:
1.81 MB
Summary
This document is page 27 of a 2017 report by Ackrell Capital titled 'Cannabis Science 101'. It details the THC/CBD formulation spectrum and lists medical conditions treated by different ratios (e.g., Alzheimer's, Cancer, Anxiety). The text explains the 'entourage effect,' the role of terpenes like Myrcene, and the concept of 'Frankensteining' in cannabis formulations. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024663', indicating it was part of a document production for a congressional investigation.
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC | ||
| FINRA | ||
| SIPC | ||
| House Oversight Committee |
Key Quotes (3)
"The 'entourage effect' refers to the overall user experience produced by the interactions among all active compounds in the cannabis plant."Source
HOUSE_OVERSIGHT_024663.jpg
Quote #1
"Many cannabinoid and terpene formulations developed for therapeutic applications are created by combining extracts from multiple cannabis strains, a process known as 'Frankensteining.'"Source
HOUSE_OVERSIGHT_024663.jpg
Quote #2
"CBD is believed to regulate the psychoactive effects of THC and reduce short-term memory loss, sleepiness and paranoia that may be caused by THC."Source
HOUSE_OVERSIGHT_024663.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document